[ Price : $8.95]
A DC federal court rules that HHS acted properly in redacting and withholding some documents sought by CDRH whistleblowers.[ Price : $8.95]
Leaders of six higher education associations ask FDA for a requirement that biosimilar applicants certify their compliance with th...[ Price : $8.95]
CBER clinical reviewers tell the Vaccines and Related Biological Products Advisory Committee that Dynavax Technologies Heplisav ap...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites The Avalon Effect, Health Breakthroughs, I. Shay Cosmetics, Mushroon Wisdom, and...[ Price : $8.95]
FDAs Nonprescription Drugs Advisory Committee delivers a mixed vote for a Merck proposal to market an over-the counter version of ...[ Price : $8.95]
FDA gives the sister company of troubled drug compounder New England Compounding Center a 20-page FDA-483 after a month-long inspe...[ Price : $8.95]
FDA approves a Watson Laboratories ANDA for a generic copy of Pfizers Revatio.[ Price : $8.95]
Abbott says it is moving into a Phase 3 trial a triple combination of investigational antiviral drugs for treating hepatitis C (HC...